To explore the possibility of NIR fluorescence intra-operative angiography of the meniscus using ICG in patients undergoing total knee arthroplasty
ID
Source
Brief title
Condition
- Tendon, ligament and cartilage disorders
- Bone and joint therapeutic procedures
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
Visibility of meniscal vascularization
Secondary outcome
For the secondary objectives, the extent of the vascularization as determined
based on NIR fluorescence intra-operative angiography (defined as mm from outer
edge of meniscus) will be compared with the extent of the vascularization as
determined based on histology (defined as mm from outer edge of meniscus).
Background summary
The menisci act as a shock absorbers within the knee and are therefore of
paramount importance for the preservation of cartilage. Further, they play an
important role in the stability of the knee. A meniscal tear is one of the most
frequent pathologies treated by orthopaedic surgeons. Whenever possible, a
meniscal tear will be repaired with sutures to ensure its critical role within
the knee joint. However, such meniscal repair is only feasible when the tear is
localized within the vascularized region of the meniscus. Despite careful
patient selection, improved surgical techniques and postoperative
rehabilitation, failure rates of meniscal repair of up to 30-40% have been
documented. One of the potential reasons for failure of meniscal repair is the
current inability to visualize whether the meniscal repair sutures are placed
within viable, vascularized meniscal tissue. Intra-operative near infrared
fluorescence angiography of the meniscus using ICG could guide the orthopaedic
surgeon in the decision which meniscal tear could be repaired. This pilot study
will explore the possibility of near-infrared fluorescence angiography of the
meniscus in patients undergoing a total knee prosthesis. Further research will
be necessary to explore the possibility of performing NIR angiography
arthroscopically.
Study objective
To explore the possibility of NIR fluorescence intra-operative angiography of
the meniscus using ICG in patients undergoing total knee arthroplasty
Study design
This trial is a phase II singlecenter, single-arm study to assess the
possibility of NIR fluorescence intra-operative angiography of the meniscus
using ICG in patients undergoing total knee arthroplasty. All patients will
undergo standard-of-care. This includes a pre-operative AP and lateral X-ray of
the knee. In addition to the standard-of-care, during the total knee
arthroplasty patients receive a single intravenous (IV) dose of 10 mg ICG. NIR
fluorescence imaging will be performed prior to the routine resection of the
medial and lateral meniscus. Fluorescence spots and fluorescence at the end of
zone 2 will be tagged with a suture. After resection of the menisci, both
menisci will be stored in formaldehyde and send to the pathology department.
The end of vascularity in zone 2 and 2 random fluorescence spots that are
marked with a suture will be checked for vascularization in histological
sections. Standard of care will proceed.
Study burden and risks
During surgery of the total knee prosthesis, 10 mg of ICG will be administred
intravenously and ICG-NIRF imaging of the vascularization of the meniscus will
be performed. This will take 15 minutes. Further, standard of care (surgery)
will proceed afterwards.
Albinusdreef 2
Leiden 2333 ZA
NL
Albinusdreef 2
Leiden 2333 ZA
NL
Listed location countries
Age
Inclusion criteria
* 18 years or older; * Patients undergoing a total knee arthroplasty * No history of allergy to iodine, shellfish or ICG; * Not pregnant; * Absence of any psychological, familial sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule; those conditions should be discussed with the patient before registration in the trial; * Before patient registration, written consent must be given according to ICH/GCP, national and local regulations.
Exclusion criteria
- History of allergy to iodine, shellfish or ICG; - Hemodialyse - Patients with hyperthyroidism; - Pregnant or lactating woman; - Any condition that in the opinion of the investigator could potentially jeopardize the health status of the patient. - Patients with severe liver failure
Design
Recruitment
metc-ldd@lumc.nl
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL63339.058.17 |